Lilly clearly has an abundance of growth drivers -- and the list includes more than Mounjaro, Zepbound, and the six drugs ...

Defining ESG can sometimes be straightforward: it’s a finance and investing approach centered on managing risks related to ...

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are ...

More than two years after Gov. Eric Holcomb’s Indiana Economic Development Corp. quietly disclosed plans for the 9,000-acre ...

One woman wrote that Ozempic caused nausea and vomiting for an entire week, leading to abnormal blood tests. Another had ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 589.06% and ...

Unless you have been living under the rock, you’d have heard of Nvidia’s (NASDAQ: NVDA) success story. All investors want a ...

The drug companies behind blockbuster weight loss and diabetes treatments have signaled that supply problems could soon be ...

These drugs work to treat diabetes and weight loss by suppressing the appetite and lowering blood sugar and A1C—which may end ...

In today's hectic society, when convenience frequently takes precedence over health, keeping a healthy weight has gro ...

Eli Lilly is intensifying its efforts to combat imitation versions of its popular appetite-suppressing drugs, Mounjaro and ...

Lilly recently announced positive results from a pivotal clinical trial of Mounjaro that could lead to even stronger sales.